{"entity":{"type":"insider","cik":"0001296771","url":"/insider/0001296771","json_url":"/insider/0001296771.json","name":"Freund John Gordon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":105,"n_filings":55,"first":"2005-09-07","last":"2026-05-20","span_basis":"filed_date"},"name_variants":[{"name":"Freund John Gordon","source":"filing","n_filings":55,"first_seen":"2005-09-07","last_seen":"2026-05-20"}],"transactions":[{"id":6180315,"accession":"0001296771-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001296771-26-000004","line_url":"/filing/0001296771-26-000004#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20.0,"shares_display":"20","price_per_share":34.05,"price_display":"34.05","price_state":"stated","total_value":681.0,"total_display":"681.00","total_whole":"681","shares_owned_after":83952.0,"shares_owned_after_display":"83,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider"},{"id":6204857,"accession":"0001296771-26-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001296771-26-000002","line_url":"/filing/0001296771-26-000002#line-3","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4127.0,"shares_display":"4,127","price_per_share":34.54,"price_display":"34.54","price_state":"stated","total_value":142546.58,"total_display":"142,546.58","total_whole":"142,547","shares_owned_after":83972.0,"shares_owned_after_display":"83,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-18","scope":"insider"},{"id":4468588,"accession":"0001062993-25-014202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-014202","line_url":"/filing/0001062993-25-014202#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11659.0,"shares_display":"11,659","price_per_share":34.3632,"price_display":"34.36","price_state":"stated","total_value":400640.5488,"total_display":"400,640.55","total_whole":"400,641","shares_owned_after":23129.0,"shares_owned_after_display":"23,129","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-08","filed_date":"2025-08-12","scope":"insider"},{"id":4365097,"accession":"0001562180-25-005706","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-005706","line_url":"/filing/0001562180-25-005706#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12132.0,"shares_display":"12,132","price_per_share":15.9906,"price_display":"15.99","price_state":"stated","total_value":193997.9592,"total_display":"193,997.96","total_whole":"193,998","shares_owned_after":91767.0,"shares_owned_after_display":"91,767","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-08","filed_date":"2025-08-11","scope":"insider"},{"id":4247698,"accession":"0001062993-25-011425","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-011425","line_url":"/filing/0001062993-25-011425#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6601.0,"shares_display":"6,601","price_per_share":30.624,"price_display":"30.62","price_state":"stated","total_value":202149.024,"total_display":"202,149.02","total_whole":"202,149","shares_owned_after":70658.0,"shares_owned_after_display":"70,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-09","filed_date":"2025-06-11","scope":"insider"},{"id":8688454,"accession":"0001562180-23-006298","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-006298","line_url":"/filing/0001562180-23-006298#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":20.5399,"price_display":"20.54","price_state":"stated","total_value":616197.0,"total_display":"616,197.00","total_whole":"616,197","shares_owned_after":103899.0,"shares_owned_after_display":"103,899","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-11","scope":"insider"},{"id":4098644,"accession":"0001562180-21-004319","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-004319","line_url":"/filing/0001562180-21-004319#line-3","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12591.0,"shares_display":"12,591","price_per_share":31.4055,"price_display":"31.41","price_state":"stated","total_value":395426.6505,"total_display":"395,426.65","total_whole":"395,427","shares_owned_after":331366.0,"shares_owned_after_display":"331,366","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-16","scope":"insider"},{"id":4098640,"accession":"0001562180-21-004319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-004319","line_url":"/filing/0001562180-21-004319#line-2","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21511.0,"shares_display":"21,511","price_per_share":31.1067,"price_display":"31.11","price_state":"stated","total_value":669136.2237,"total_display":"669,136.22","total_whole":"669,136","shares_owned_after":343957.0,"shares_owned_after_display":"343,957","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-16","scope":"insider"},{"id":4098636,"accession":"0001562180-21-004319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-004319","line_url":"/filing/0001562180-21-004319#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17990.0,"shares_display":"17,990","price_per_share":31.2806,"price_display":"31.28","price_state":"stated","total_value":562737.994,"total_display":"562,737.99","total_whole":"562,738","shares_owned_after":365468.0,"shares_owned_after_display":"365,468","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-16","scope":"insider"},{"id":4790697,"accession":"0001562180-21-003880","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-003880","line_url":"/filing/0001562180-21-003880#line-2","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45220.0,"shares_display":"45,220","price_per_share":30.0629,"price_display":"30.06","price_state":"stated","total_value":1359444.338,"total_display":"1,359,444.34","total_whole":"1,359,444","shares_owned_after":383458.0,"shares_owned_after_display":"383,458","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-28","filed_date":"2021-06-01","scope":"insider"},{"id":4790693,"accession":"0001562180-21-003880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-003880","line_url":"/filing/0001562180-21-003880#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26367.0,"shares_display":"26,367","price_per_share":30.9297,"price_display":"30.93","price_state":"stated","total_value":815523.3999,"total_display":"815,523.40","total_whole":"815,523","shares_owned_after":428678.0,"shares_owned_after_display":"428,678","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-27","filed_date":"2021-06-01","scope":"insider"},{"id":5259017,"accession":"0001562180-21-003755","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-003755","line_url":"/filing/0001562180-21-003755#line-4","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17138.0,"shares_display":"17,138","price_per_share":31.8493,"price_display":"31.85","price_state":"stated","total_value":545833.3034,"total_display":"545,833.30","total_whole":"545,833","shares_owned_after":455045.0,"shares_owned_after_display":"455,045","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-26","filed_date":"2021-05-26","scope":"insider"},{"id":5259014,"accession":"0001562180-21-003755","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-003755","line_url":"/filing/0001562180-21-003755#line-3","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1696.0,"shares_display":"1,696","price_per_share":32.5452,"price_display":"32.55","price_state":"stated","total_value":55196.6592,"total_display":"55,196.66","total_whole":"55,197","shares_owned_after":472183.0,"shares_owned_after_display":"472,183","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-25","filed_date":"2021-05-26","scope":"insider"},{"id":5259011,"accession":"0001562180-21-003755","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-003755","line_url":"/filing/0001562180-21-003755","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51027.0,"shares_display":"51,027","price_per_share":32.54175876104807,"price_display":"32.54","price_state":"stated","total_value":1660508.3243,"total_display":"1,660,508.32","total_whole":"1,660,508","shares_owned_after":474079.0,"shares_owned_after_display":"474,079","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-26","scope":"insider","n_lines":2},{"id":5258808,"accession":"0001562180-21-002352","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-002352","line_url":"/filing/0001562180-21-002352","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":666200.0,"shares_display":"666,200","price_per_share":30.386802071450013,"price_display":"30.39","price_state":"stated","total_value":20243687.54,"total_display":"20,243,687.54","total_whole":"20,243,688","shares_owned_after":524906.0,"shares_owned_after_display":"524,906","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-17","filed_date":"2021-03-18","scope":"insider","n_lines":2},{"id":5258798,"accession":"0001562180-21-002352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-002352","line_url":"/filing/0001562180-21-002352#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55053.0,"shares_display":"55,053","price_per_share":30.3323,"price_display":"30.33","price_state":"stated","total_value":1669884.1119,"total_display":"1,669,884.11","total_whole":"1,669,884","shares_owned_after":1191106.0,"shares_owned_after_display":"1,191,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-16","filed_date":"2021-03-18","scope":"insider"},{"id":5436007,"accession":"0001562180-21-002250","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-002250","line_url":"/filing/0001562180-21-002250#line-3","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80887.0,"shares_display":"80,887","price_per_share":30.9022,"price_display":"30.90","price_state":"stated","total_value":2499586.2514,"total_display":"2,499,586.25","total_whole":"2,499,586","shares_owned_after":1246159.0,"shares_owned_after_display":"1,246,159","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-15","scope":"insider"},{"id":5436005,"accession":"0001562180-21-002250","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-002250","line_url":"/filing/0001562180-21-002250#line-2","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91072.0,"shares_display":"91,072","price_per_share":31.3912,"price_display":"31.39","price_state":"stated","total_value":2858859.3664,"total_display":"2,858,859.37","total_whole":"2,858,859","shares_owned_after":1327046.0,"shares_owned_after_display":"1,327,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-12","filed_date":"2021-03-15","scope":"insider"},{"id":5436002,"accession":"0001562180-21-002250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-002250","line_url":"/filing/0001562180-21-002250#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63928.0,"shares_display":"63,928","price_per_share":31.0465,"price_display":"31.05","price_state":"stated","total_value":1984740.652,"total_display":"1,984,740.65","total_whole":"1,984,741","shares_owned_after":1418118.0,"shares_owned_after_display":"1,418,118","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-11","filed_date":"2021-03-15","scope":"insider"},{"id":2096776,"accession":"0001562180-20-007090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-007090","line_url":"/filing/0001562180-20-007090#line-2","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47886.0,"shares_display":"47,886","price_per_share":23.393,"price_display":"23.39","price_state":"stated","total_value":1120197.198,"total_display":"1,120,197.20","total_whole":"1,120,197","shares_owned_after":1482046.0,"shares_owned_after_display":"1,482,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-04","scope":"insider"},{"id":2096773,"accession":"0001562180-20-007090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-007090","line_url":"/filing/0001562180-20-007090#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":23.2848,"price_display":"23.28","price_state":"stated","total_value":2328480.0,"total_display":"2,328,480.00","total_whole":"2,328,480","shares_owned_after":1529932.0,"shares_owned_after_display":"1,529,932","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-02","filed_date":"2020-12-04","scope":"insider"},{"id":2617812,"accession":"0001562180-20-006399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-006399","line_url":"/filing/0001562180-20-006399#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":190053.0,"shares_display":"190,053","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":4181166.0,"total_display":"4,181,166.00","total_whole":"4,181,166","shares_owned_after":2129932.0,"shares_owned_after_display":"2,129,932","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-19","filed_date":"2020-10-20","scope":"insider"},{"id":2587808,"accession":"0001209191-20-051490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-051490","line_url":"/filing/0001209191-20-051490#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":4800000.0,"total_display":"4,800,000.00","total_whole":"4,800,000","shares_owned_after":560053.0,"shares_owned_after_display":"560,053","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-18","filed_date":"2020-09-22","scope":"insider"},{"id":3172017,"accession":"0001209191-20-050511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-050511","line_url":"/filing/0001209191-20-050511#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":960053.0,"shares_owned_after_display":"960,053","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-11","filed_date":"2020-09-15","scope":"insider"},{"id":3017778,"accession":"0001209191-20-047981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047981","line_url":"/filing/0001209191-20-047981#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":8.72,"price_display":"8.72","price_state":"stated","total_value":4360000.0,"total_display":"4,360,000.00","total_whole":"4,360,000","shares_owned_after":1460053.0,"shares_owned_after_display":"1,460,053","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-19","filed_date":"2020-08-21","scope":"insider"},{"id":3190370,"accession":"0001562180-20-005448","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-005448","line_url":"/filing/0001562180-20-005448#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":null,"owner_name":"Freund John Gordon; Skyline Venture Management V, LLC; Skyline Venture Partners V LP","owner_display_name":"Freund John Gordon","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":21.5,"price_display":"21.50","price_state":"stated","total_value":21500000.0,"total_display":"21,500,000.00","total_whole":"21,500,000","shares_owned_after":2819985.0,"shares_owned_after_display":"2,819,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-08-14","scope":"insider"},{"id":7873705,"accession":"0001209191-19-060298","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-060298","line_url":"/filing/0001209191-19-060298","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15031.0,"shares_display":"15,031","price_per_share":2.19,"price_display":"2.19","price_state":"stated","total_value":32917.89,"total_display":"32,917.89","total_whole":"32,918","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-12","scope":"insider","n_lines":2},{"id":8630352,"accession":"0001562180-19-004500","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-004500","line_url":"/filing/0001562180-19-004500#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152424.0,"shares_display":"152,424","price_per_share":18.4038,"price_display":"18.40","price_state":"stated","total_value":2805180.8112,"total_display":"2,805,180.81","total_whole":"2,805,181","shares_owned_after":3819985.0,"shares_owned_after_display":"3,819,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-26","filed_date":"2019-08-27","scope":"insider"},{"id":8577975,"accession":"0001562180-19-004460","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-19-004460","line_url":"/filing/0001562180-19-004460#line-4","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180.0,"shares_display":"180","price_per_share":20.03,"price_display":"20.03","price_state":"stated","total_value":3605.4,"total_display":"3,605.40","total_whole":"3,605","shares_owned_after":3972409.0,"shares_owned_after_display":"3,972,409","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-23","scope":"insider"},{"id":8577971,"accession":"0001562180-19-004460","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-19-004460","line_url":"/filing/0001562180-19-004460#line-3","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2185.0,"shares_display":"2,185","price_per_share":20.049,"price_display":"20.05","price_state":"stated","total_value":43807.065,"total_display":"43,807.06","total_whole":"43,807","shares_owned_after":3972589.0,"shares_owned_after_display":"3,972,589","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-22","filed_date":"2019-08-23","scope":"insider"},{"id":8577967,"accession":"0001562180-19-004460","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-19-004460","line_url":"/filing/0001562180-19-004460","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45211.0,"shares_display":"45,211","price_per_share":20.151227721129814,"price_display":"20.15","price_state":"stated","total_value":911057.1565,"total_display":"911,057.16","total_whole":"911,057","shares_owned_after":3992918.0,"shares_owned_after_display":"3,992,918","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-21","filed_date":"2019-08-23","scope":"insider","n_lines":2},{"id":8041957,"accession":"0001562180-19-004288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-004288","line_url":"/filing/0001562180-19-004288#line-1","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":18.25,"price_display":"18.25","price_state":"stated","total_value":7300000.0,"total_display":"7,300,000.00","total_whole":"7,300,000","shares_owned_after":4019985.0,"shares_owned_after_display":"4,019,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-14","scope":"insider"},{"id":6830356,"accession":"0001209191-18-055697","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-055697","line_url":"/filing/0001209191-18-055697#line-5","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":325000.0,"shares_display":"325,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4875000.0,"total_display":"4,875,000.00","total_whole":"4,875,000","shares_owned_after":4419985.0,"shares_owned_after_display":"4,419,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-19","filed_date":"2018-10-19","scope":"insider"},{"id":6708054,"accession":"0001209191-18-055698","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-055698","line_url":"/filing/0001209191-18-055698#line-5","is_derivative":false,"issuer_cik":"0001277503","issuer_name":"SI-BONE, Inc.","issuer_ticker":"SIBN","issuer_name_source":null,"issuer_url":"/issuer/0001277503","owner_cik":null,"owner_name":"Skyline Venture Partners V LP; KANEKO YASUNORI; Skyline Venture Management V, LLC; Freund John Gordon","owner_display_name":"Skyline Venture Partners V LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":325000.0,"shares_display":"325,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4875000.0,"total_display":"4,875,000.00","total_whole":"4,875,000","shares_owned_after":4419985.0,"shares_owned_after_display":"4,419,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-19","filed_date":"2018-10-19","scope":"insider"},{"id":8803710,"accession":"0001209191-15-080108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-080108","line_url":"/filing/0001209191-15-080108#line-1","is_derivative":false,"issuer_cik":"0001130591","issuer_name":"XENOPORT INC","issuer_ticker":"XNPT","issuer_name_source":null,"issuer_url":"/issuer/0001130591","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":909.0,"shares_display":"909","price_per_share":6.6822,"price_display":"6.68","price_state":"stated","total_value":6074.1198,"total_display":"6,074.12","total_whole":"6,074","shares_owned_after":488560.0,"shares_owned_after_display":"488,560","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-11","filed_date":"2015-11-13","scope":"insider"},{"id":8406397,"accession":"0001192482-15-000195","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001192482-15-000195","line_url":"/filing/0001192482-15-000195#line-4","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":1800000.0,"total_display":"1,800,000.00","total_whole":"1,800,000","shares_owned_after":2949916.0,"shares_owned_after_display":"2,949,916","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-12","filed_date":"2015-05-13","scope":"insider"},{"id":8533674,"accession":"0001209191-15-018139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-018139","line_url":"/filing/0001209191-15-018139#line-1","is_derivative":false,"issuer_cik":"0001277503","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001277503","owner_cik":null,"owner_name":"Freund John Gordon; Skyline Venture Management V, LLC; KANEKO YASUNORI; Skyline Venture Partners V LP","owner_display_name":"Freund John Gordon","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37532.0,"shares_display":"37,532","price_per_share":26.02,"price_display":"26.02","price_state":"stated","total_value":976582.64,"total_display":"976,582.64","total_whole":"976,583","shares_owned_after":1719671.0,"shares_owned_after_display":"1,719,671","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-20","filed_date":"2015-02-24","scope":"insider"},{"id":7044702,"accession":"0001104659-14-074948","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-14-074948","line_url":"/filing/0001104659-14-074948#line-3","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"PROTEON THERAPEUTICS INC","issuer_ticker":"PRTO","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56038.0,"shares_display":"56,038","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":560380.0,"total_display":"560,380.00","total_whole":"560,380","shares_owned_after":1432930.0,"shares_owned_after_display":"1,432,930","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-27","filed_date":"2014-10-29","scope":"insider"},{"id":7044700,"accession":"0001104659-14-074948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-14-074948","line_url":"/filing/0001104659-14-074948#line-2","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"PROTEON THERAPEUTICS INC","issuer_ticker":"PRTO","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","total_whole":"2,000,000","shares_owned_after":200000.0,"shares_owned_after_display":"200,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-27","filed_date":"2014-10-29","scope":"insider"},{"id":6692498,"accession":"0001104659-14-074955","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-14-074955","line_url":"/filing/0001104659-14-074955#line-3","is_derivative":false,"issuer_cik":"0001277503","issuer_name":"PROTEON THERAPEUTICS INC","issuer_ticker":"PRTO","issuer_name_source":null,"issuer_url":"/issuer/0001277503","owner_cik":null,"owner_name":"KANEKO YASUNORI; Skyline Venture Partners Qualified Purchaser Fund IV L P; Freund John Gordon; Skyline Venture Management IV, LLC","owner_display_name":"KANEKO YASUNORI","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56038.0,"shares_display":"56,038","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":560380.0,"total_display":"560,380.00","total_whole":"560,380","shares_owned_after":1432930.0,"shares_owned_after_display":"1,432,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-27","filed_date":"2014-10-29","scope":"insider"},{"id":6692496,"accession":"0001104659-14-074955","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-14-074955","line_url":"/filing/0001104659-14-074955#line-2","is_derivative":false,"issuer_cik":"0001277503","issuer_name":"PROTEON THERAPEUTICS INC","issuer_ticker":"PRTO","issuer_name_source":null,"issuer_url":"/issuer/0001277503","owner_cik":null,"owner_name":"KANEKO YASUNORI; Skyline Venture Partners Qualified Purchaser Fund IV L P; Freund John Gordon; Skyline Venture Management IV, LLC","owner_display_name":"KANEKO YASUNORI","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","total_whole":"2,000,000","shares_owned_after":200000.0,"shares_owned_after_display":"200,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-27","filed_date":"2014-10-29","scope":"insider"},{"id":7075188,"accession":"0001209191-14-061793","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-061793","line_url":"/filing/0001209191-14-061793","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105588.0,"shares_display":"105,588","price_per_share":20.941264672121832,"price_display":"20.94","price_state":"stated","total_value":2211146.2542,"total_display":"2,211,146.25","total_whole":"2,211,146","shares_owned_after":890146.0,"shares_owned_after_display":"890,146","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-02","filed_date":"2014-10-03","scope":"insider","n_lines":2},{"id":7075184,"accession":"0001209191-14-061793","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-061793","line_url":"/filing/0001209191-14-061793","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":142146.0,"shares_display":"142,146","price_per_share":20.842870026592376,"price_display":"20.84","price_state":"stated","total_value":2962730.6028,"total_display":"2,962,730.60","total_whole":"2,962,731","shares_owned_after":995734.0,"shares_owned_after_display":"995,734","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-03","scope":"insider","n_lines":2},{"id":6914131,"accession":"0001209191-14-060522","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-060522","line_url":"/filing/0001209191-14-060522#line-2","is_derivative":false,"issuer_cik":"0001296771","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001296771","owner_cik":"0001296771","owner_name":"Freund John Gordon","owner_display_name":"Freund John Gordon","owner_url":"/insider/0001296771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56618.0,"shares_display":"56,618","price_per_share":20.1675,"price_display":"20.17","price_state":"stated","total_value":1141843.515,"total_display":"1,141,843.52","total_whole":"1,141,844","shares_owned_after":1137880.0,"shares_owned_after_display":"1,137,880","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-30","filed_date":"2014-10-01","scope":"insider"}],"collapsed":true,"next_cursor":"2014-09-30|6914131","ledger_fault":false,"count":{"value":95,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":41,"open_market":true},{"code":"S","label":"Open-market sale","n":54,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":95},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267565","name":"COLLEGIUM PHARMACEUTICAL, INC","url":"/issuer/0001267565","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2015-05-13","last_seen":"2026-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001459839","name":"SI-BONE, Inc.","url":"/issuer/0001459839","role":"Director, Ten percent owner","n_filings":15,"first_seen":"2018-10-19","last_seen":"2025-08-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001382101","name":"SUTRO BIOPHARMA, INC.","url":"/issuer/0001382101","role":"Director","n_filings":3,"first_seen":"2020-08-21","last_seen":"2020-09-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001373707","name":"TETRAPHASE PHARMACEUTICALS INC","url":"/issuer/0001373707","role":"Director, Ten percent owner","n_filings":10,"first_seen":"2013-03-27","last_seen":"2019-12-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001130591","name":"XENOPORT INC","url":"/issuer/0001130591","role":"Director","n_filings":9,"first_seen":"2005-09-07","last_seen":"2015-11-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001399529","name":"Dicerna Pharmaceuticals Inc","url":"/issuer/0001399529","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2014-02-05","last_seen":"2015-02-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001359931","name":"PROTEON THERAPEUTICS INC","url":"/issuer/0001359931","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2014-10-29","last_seen":"2014-10-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001367920","name":"CONCERT PHARMACEUTICALS, INC.","url":"/issuer/0001367920","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2014-02-21","last_seen":"2014-02-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001427925","name":"ACELRX PHARMACEUTICALS INC","url":"/issuer/0001427925","role":"Ten percent owner","n_filings":2,"first_seen":"2011-02-18","last_seen":"2012-05-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001411861","name":"MAKO Surgical Corp.","url":"/issuer/0001411861","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2009-08-25","last_seen":"2010-12-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001401923","name":"MAP Pharmaceuticals, Inc.","url":"/issuer/0001401923","role":"Director","n_filings":2,"first_seen":"2007-10-09","last_seen":"2010-03-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001276591","name":"HANSEN MEDICAL INC","url":"/issuer/0001276591","role":"Director","n_filings":1,"first_seen":"2009-04-21","last_seen":"2009-04-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001296771","retrieved_at":"2026-08-23T19:43:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}